Background Emergence of artemisinin resistance in southeast Asia poses a serious threat
to the global control of Plasmodium falciparum malaria. Discovery of the K13 marker has …

Malaria remains a major burden on global health, with roughly 200 million cases worldwide
and more than 400,000 deaths per year. Besides biomedical research and political efforts, …

Malaria is a blood disease caused by the Plasmodium parasites transmitted through the bite
of female Anopheles mosquito. Microscopists commonly examine thick and thin blood …

Background Artemisinin and partner-drug resistance in Plasmodium falciparum are major
threats to malaria control and elimination. Triple artemisinin-based combination therapies (…

Background The emergence and spread of resistance in Plasmodium falciparum malaria to
artemisinin combination therapies in the Greater Mekong subregion poses a major threat to …

Malaria is a major global health threat. The standard way of diagnosing malaria is by visually
examining blood smears for parasite-infected red blood cells under the microscope by …

Scrub typhus is transmitted by trombiculid mites and is endemic to East and Southeast Asia
and Northern Australia. The clinical syndrome classically consists of a fever, rash, and eschar…

Background A multidrug-resistant co-lineage of Plasmodium falciparum malaria, named
KEL1/PLA1, spread across Cambodia in 2008–13, causing high rates of treatment failure with …

Background Preventing the emergence of anti-malarial drug resistance is critical for the success
of current malaria elimination efforts. Prevention strategies have focused predominantly …

Background Artemisinin combination therapy (ACT) is now the recommended first-line treatment
for falciparum malaria throughout the world. Initiatives to eliminate malaria are critically …